INTERCEPT PHARMACEUTICALS, INC.·4

Feb 14, 7:01 PM ET

Sullivan Ryan T 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Feb 14, 2019

Insider Transaction Report

Form 4
Period: 2019-02-13
Sullivan Ryan T
General Counsel
Transactions
  • Tax Payment

    Common Stock

    2019-02-13$110.35/sh1,971$217,50027,829 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person.

Documents

1 file
  • 4
    tv513734_4.xmlPrimary

    OWNERSHIP DOCUMENT